AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25762357 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + PRF + 1% MF
Number of subjects: 120
Study 25762357 — intervention group
Group type: COMPARATOR
Intervention: OFD alone
Number of subjects: 120
Study 23751236 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000mcg chromium/day (high dose)
Number of subjects: 24
Study 23751236 — intervention group
Group type: EXPERIMENTAL
Intervention: 600mcg chromium/day (moderate dose)
Number of subjects: 24
Study 23751236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21523925 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymph drainage (MLD) once a week for 5 weeks
Number of subjects: 35
Study 21523925 — intervention group
Group type: COMPARATOR
Intervention: Observation group (control)
Number of subjects: 35
Study 19090875 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (3 doses)
Number of subjects: 240
Study 19090875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 16531393 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-Hz metronome
Number of subjects: 0
Study 16531393 — intervention group
Group type: COMPARATOR
Intervention: 2-Hz metronome
Number of subjects: 0
Study 12769159 — intervention group
Group type: EXPERIMENTAL
Intervention: HDk lenses
Number of subjects: 134
Study 12769159 — intervention group
Group type: COMPARATOR
Intervention: LDk lenses
Number of subjects: 134
Study 10669265 — intervention group
Group type: EXPERIMENTAL
Intervention: PaO2 during anaesthesia with F(I)O2=0.33
Number of subjects: 40
Study 10669265 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking more than 20 pack-years
Number of subjects: 40
Study 9062374 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants (sertraline and imipramine)
Number of subjects: 410
Study 9062374 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 410
Study 9062374 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 410
Study 8376215 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral sound stimulation (NBN frequencies centered between 0.25 and 8 kHz)
Number of subjects: 39
Study 8376215 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral sound stimulation (NBN frequencies centered around 1 kHz)
Number of subjects: 39
Study 8376215 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral sound stimulation (NBN frequencies around 2 kHz and lower frequencies around 1 kHz)
Number of subjects: 39
Study 3085552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 3 micrograms/kg (group 1, n = 6)
Number of subjects: 46
Study 3085552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 8 micrograms/kg (group 2, n = 20)
Number of subjects: 46
Study 3085552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 3 micrograms/kg plus continuous intravenous nitroglycerin infusion 0.9 microgram X kg‐1 X min‐1 (group 3, n = 20)
Number of subjects: 46
Study 30182786 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-42847922 (5-60 mg orally once daily for 10 days)
Number of subjects: 8
Study 30182786 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-42847922 (doses >5 mg)
Number of subjects: 8
Study 30182786 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-42847922 (doses >10 mg)
Number of subjects: 8
Study 30182786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 27154159 — intervention group
Group type: COMPARATOR
Intervention: 5 mg/kg intravenous methylprednisolone
Number of subjects: 30
Study 27154159 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg intravenous methylprednisolone
Number of subjects: 30
Study 24943472 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport-for-development programme (11-week voluntary competitive football league)
Number of subjects: 1462
Study 22864179 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10mg daily
Number of subjects: 130
Study 22864179 — intervention group
Group type: COMPARATOR
Intervention: Famotidine 20mg daily
Number of subjects: 130
Study 21260940 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency intravesical electroneurostimulation with magnetophoresis of oxibutinin
Number of subjects: 0
Study 21260940 — intervention group
Group type: COMPARATOR
Intervention: Oral intake of oxibutinin
Number of subjects: 0
Study 21260940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (intravesical electroneurostimulation and magnetophoresis)
Number of subjects: 0
Study 18832294 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambrisentan 10 mg alone
Number of subjects: 19
Study 18832294 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 20 mg 3 times daily after 7 days of ambrisentan 10 mg once daily
Number of subjects: 19
Study 18832294 — intervention group
Group type: EXPERIMENTAL
Intervention: N-desmethyl sildenafil
Number of subjects: 19
Study 15963399 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose furosemide (500 to 1,000 mg) plus hypertonic saline solution (HSS) twice a day for four to six days
Number of subjects: 94
Study 15963399 — intervention group
Group type: COMPARATOR
Intervention: High-dose furosemide (500 to 1,000 mg) alone, twice a day for four to six days
Number of subjects: 94
Study 12835083 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (Group I)
Number of subjects: 52
Study 12835083 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (Group II)
Number of subjects: 52
Study 12835083 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 10829126 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional slide exposure with self-relevant instructions
Number of subjects: 0
Study 10829126 — intervention group
Group type: EXPERIMENTAL
Intervention: Original design of Christianson and E.F. Loftus (1991)
Number of subjects: 0
Study 10829126 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic variation of stimulus exposure and interstimulus interval durations
Number of subjects: 0
Study 8723803 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Intervention (KMI) including kangaroo position, kangaroo nutrition, and kangaroo discharge policies
Number of subjects: 0
Study 1947785 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 24
Study 1947785 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 6223430 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectinomycin
Number of subjects: 32
Study 6223430 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 32
Study 31969977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 International Units once daily for 4 weeks)
Number of subjects: 40
Study 31969977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 40
Study 30865782 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based delivery
Number of subjects: 421
Study 30865782 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group delivery
Number of subjects: 421
Study 30865782 — intervention group
Group type: COMPARATOR
Intervention: Literature control
Number of subjects: 421
Study 29062019 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern recognition control
Number of subjects: 8
Study 29062019 — intervention group
Group type: COMPARATOR
Intervention: Direct control
Number of subjects: 8
Study 25701159 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard parenteral nutrition with glutamine supplementation (SPN + Gln)
Number of subjects: 98
Study 25701159 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral nutrition (SPN)
Number of subjects: 98
Study 24057919 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible light‐cured resin (VLCR) dentures
Number of subjects: 52
Study 24057919 — intervention group
Group type: COMPARATOR
Intervention: Conventional poly(methyl methacrylate) (PMMA) dentures
Number of subjects: 52
Study 22052028 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise at intensities of 10, 12, 14, 15 and 16 km/h (0% gradient)
Number of subjects: 20
Study 22052028 — intervention group
Group type: COMPARATOR
Intervention: Cycle ergometer exercise at intensities of 80, 120, 160, 180 and 200 W (65‐70 rpm)
Number of subjects: 20
Study 22052028 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill and cycle ergometer exercise
Number of subjects: 20
Study 19539361 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5-20 mg, once daily or twice daily)
Number of subjects: 3491
Study 19539361 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 3491
Study 19539361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3491
Study 17292895 — intervention group
Group type: COMPARATOR
Intervention: 600 IU of recombinant follicle-stimulating hormone (FSH) as the control group (group A)
Number of subjects: 170
Study 17292895 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU of recombinant FSH plus daily supplementation with 75 IU of recombinant luteinizing hormone (group B)
Number of subjects: 170
Study 17292895 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU of recombinant FSH plus daily supplementation with 75 IU of recombinant hCG (group C)
Number of subjects: 170
Study 15238155 — intervention group
Group type: EXPERIMENTAL
Intervention: International Postage Vouchers
Number of subjects: 0
Study 15238155 — intervention group
Group type: COMPARATOR
Intervention: No return postage
Number of subjects: 0
Study 11575982 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg, orally, 4 times daily for 2 days
Number of subjects: 201
Study 11575982 — intervention group
Group type: COMPARATOR
Intervention: Placebo, orally, 4 times daily for 2 days
Number of subjects: 201
Study 10230643 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy with metformin
Number of subjects: 26
Study 10230643 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy without metformin
Number of subjects: 26
Study 8556969 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 16
Study 8556969 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 16
Study 8556969 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Methadone and Clonidine
Number of subjects: 16
Study 2528477 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy after salpingo‐ovariolysis
Number of subjects: 0
Study 2528477 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy after salpingostomy
Number of subjects: 0
Study 2528477 — intervention group
Group type: COMPARATOR
Intervention: Expectant observation after salpingo‐ovariolysis
Number of subjects: 0
Study 2528477 — intervention group
Group type: COMPARATOR
Intervention: Expectant observation after salpingostomy
Number of subjects: 0
Study 2528477 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy
Number of subjects: 0
Study 826960 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline injections
Number of subjects: 10
Study 30572378 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support education mode
Number of subjects: 300
Study 30572378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 26534874 — intervention group
Group type: EXPERIMENTAL
Intervention: 400μg buccal misoprostol
Number of subjects: 120
Study 26534874 — intervention group
Group type: COMPARATOR
Intervention: 800μg placebo buccal
Number of subjects: 120
Study 24585400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active women (engaging in at least 150 min of moderate-intensity leisure-time physical activity per week)
Number of subjects: 338
Study 24585400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active women
Number of subjects: 338
Study 22764598 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion pretreatment of Guanyuan (CV 12) + bilateral Zusanli (ST 36) or Guanyuan (CV 12) + bilateral Sanyinjiao (SP 6) for 30 min, once a day for 4 weeks
Number of subjects: 12
Study 22764598 — intervention group
Group type: COMPARATOR
Intervention: Control group: simple heavy load running training
Number of subjects: 12
Study 20508907 — intervention group
Group type: EXPERIMENTAL
Intervention: Idraparinux (2.5 mg, once-weekly subcutaneous injection)
Number of subjects: 421
Study 20508907 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (heparin followed by vitamin K antagonists)
Number of subjects: 421
Study 20508907 — intervention group
Group type: EXPERIMENTAL
Intervention: Idraparinux
Number of subjects: 421
Study 20508907 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 421
Study 18251334 — intervention group
Group type: EXPERIMENTAL
Intervention: Body fat percentage (BF%)
Number of subjects: 451
Study 18251334 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 451
Study 18251334 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference (WC)
Number of subjects: 451
Study 18251334 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI/WC as obesity measures
Number of subjects: 451
Study 15821527 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Stimulation (FMS)
Number of subjects: 39
Study 15821527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 11321205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 54
Study 11321205 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire safety education (FSE)
Number of subjects: 54
Study 11321205 — intervention group
Group type: COMPARATOR
Intervention: Home visit from a firefighter (HVF)
Number of subjects: 54
Study 9769818 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced three-dimensional MR angiography
Number of subjects: 21
Study 8142791 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed treatment manual
Number of subjects: 81
Study 8142791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 81
Study 8142791 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 81
Study 3344301 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosituational feedback
Number of subjects: 64
Study 3344301 — intervention group
Group type: COMPARATOR
Intervention: Internal cue feedback
Number of subjects: 64
Study 3344301 — intervention group
Group type: COMPARATOR
Intervention: Situational cue feedback
Number of subjects: 64
Study 3344301 — intervention group
Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 64
Study 2131504 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids supplementation added to a protein restricted diet (0.6 g/kg/day)
Number of subjects: 0
Study 2131504 — intervention group
Group type: COMPARATOR
Intervention: Control diet containing food with high biologic value
Number of subjects: 0
Study 134723 — intervention group
Group type: EXPERIMENTAL
Intervention: ipratropiumbromide (0.02 mg per puff, 3 x 2 puffs)
Number of subjects: 25
Study 134723 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 30739406 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional barbed suture
Number of subjects: 96
Study 30739406 — intervention group
Group type: COMPARATOR
Intervention: PDS‐Ⅱ suture (control group)
Number of subjects: 96
Study 27440140 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D health utility score
Number of subjects: 616
Study 27440140 — intervention group
Group type: COMPARATOR
Intervention: Acute illness variables
Number of subjects: 616
Study 25913498 — intervention group
Group type: EXPERIMENTAL
Intervention: SoluMatrix diclofenac 35 mg b.i.d. (which could be increased to t.i.d. as needed)
Number of subjects: 602
Study 23912164 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based psycho-educational intervention for parents (AfterTheInjury.org [ATI])
Number of subjects: 100
Study 23912164 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 21088959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (0.5 mg)
Number of subjects: 36
Study 21088959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 19207134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) 10 mmol
Number of subjects: 48
Study 19207134 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NSal)
Number of subjects: 48
Study 17429905 — intervention group
Group type: EXPERIMENTAL
Intervention: PurFlo mattress
Number of subjects: 24
Study 17429905 — intervention group
Group type: COMPARATOR
Intervention: Conventional mattress
Number of subjects: 24
Study 15109586 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitative approaches
Number of subjects: 0
Study 15109586 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological or surgical treatment
Number of subjects: 0
Study 11394513 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprietary propofol
Number of subjects: 40
Study 10085701 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese diabetic patients (BMI > 27.5)
Number of subjects: 63
Study 10085701 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients without diabetes (BMI > 27.5)
Number of subjects: 63
Study 10085701 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal weight diabetic patients (BMI < 27.5)
Number of subjects: 63
Study 8291729 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia only (EA)
Number of subjects: 96
Study 8291729 — intervention group
Group type: COMPARATOR
Intervention: Combined epidural and general anesthesia (EG)
Number of subjects: 96
Study 8291729 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (GA)
Number of subjects: 96
Study 2587002 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (3 cycles)
Number of subjects: 60
Study 2587002 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and surgery or radiotherapy
Number of subjects: 60
Study 2587002 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive multimodal approach (including surgery)
Number of subjects: 60
Study 31904695 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostasis with the TR Band device
Number of subjects: 600
Study 31904695 — intervention group
Group type: COMPARATOR
Intervention: Conventional pressure dressing
Number of subjects: 600
Study 31582271 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupation-based bilateral upper extremity training
Number of subjects: 20
Study 31582271 — intervention group
Group type: COMPARATOR
Intervention: Task-based bilateral upper extremity training
Number of subjects: 20
Study 29488475 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs and an anxiolytic (adaptol)
Number of subjects: 125
Study 29488475 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive drugs only
Number of subjects: 125
Study 25361980 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus everolimus
Number of subjects: 55
Study 25361980 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 55
Study 23475369 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplement
Number of subjects: 100
Study 23475369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 21849041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine plus gemcitabine followed by docetaxel (VGD)
Number of subjects: 68
Study 21849041 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 68
Study 19308789 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg caffeine . kg(‐1) body mass (BM)
Number of subjects: 7
Study 19308789 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg caffeine . kg(‐1) BM
Number of subjects: 7
Study 19308789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 16393442 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 100 mg
Number of subjects: 107
Study 16393442 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg
Number of subjects: 107
Study 16393442 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 200 mg
Number of subjects: 107
Study 16393442 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 300 mg
Number of subjects: 107
Study 16393442 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 107
Study 16393442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 15261318 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 50
Study 15261318 — intervention group
Group type: COMPARATOR
Intervention: i.v. thiopental
Number of subjects: 50
Study 11323595 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable rigidity colonoscope (VRC)
Number of subjects: 50
Study 11323595 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscope
Number of subjects: 50
Study 9396910 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of dexamethasone in saline solution (study group, n = 50)
Number of subjects: 98
Study 9396910 — intervention group
Group type: COMPARATOR
Intervention: Saline solution only (control group, n = 48)
Number of subjects: 98
Study 9396910 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (comparison of risks)
Number of subjects: 98
Study 9396910 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (general success rate)
Number of subjects: 98
Study 8192695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 14
Study 8192695 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 14
Study 2879174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (10 micrograms/kg intravenously)
Number of subjects: 16
Study 2879174 — intervention group
Group type: COMPARATOR
Intervention: Non-fentanyl (nitrous oxide and d‐tubocurarine without fentanyl)
Number of subjects: 16
Study 31240753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord clamping after 180 seconds
Number of subjects: 540
Study 31240753 — intervention group
Group type: COMPARATOR
Intervention: Cord clamping within 60 seconds
Number of subjects: 540
Study 29522941 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion-SSRI combination
Number of subjects: 662
Study 29522941 — intervention group
Group type: COMPARATOR
Intervention: SSRI monotherapy
Number of subjects: 662